Societe Generale SA Stabilisation Notice - SANOFI (9505I)
April 06 2020 - 9:46AM
UK Regulatory
TIDM0A2V
RNS Number : 9505I
Societe Generale SA
06 April 2020
Date: 06/04/2020
Not for the distribution, directly or indirectly in to the
United States or any jurisdiction in which such distribution would
be unlawful.
SANOFI - Stabilisation Notice
Societe Generale (Contact: RONAN MURPHY; telephone:
+44-20-7676-7463) hereby gives notice that the Stabilising
Manager(s) named below may stabilise the offer of the following
securities in accordance with Commission Regulation (EC) No.
2273/2003 implementing the Market Abuse Directive
(2003/6/EC).ty
The Securities:
============================================ ============================================
Issuer: SANOFI
============================================ ============================================
Guarantor (if any): n/a
============================================ ============================================
Aggregate Nominal Amount: EUR 250m, EUR 250m
============================================ ============================================
Description: Maturity: 1(st) April 2025,
1(st) April 2030
============================================ ============================================
Offer price: 102.427, 106.539
============================================ ============================================
Stabilisation:
============================================ ============================================
Stabilising managers: SG CIB
============================================ ============================================
Stabilisation Period expected 06/04/2020
to start on:
============================================ ============================================
Stabilisation period expected 08/05/2020
to end no later than:
============================================ ============================================
Existence, maximum size The Stabilising Manager(s)
and conditions of use of may over-allot the securities
over-allotment facility: to the extent permitted
in accordance with SG's
Policy.
============================================ ============================================
In connection with the offer of the above securities, the
Stabilising Manager(s) may over-allot the securities or effect
transactions with a view to supporting the market price of the
securities at a level higher than that which might otherwise
prevail. However, there is no assurance that the Stabilising
Manager(s) will take any Stabilising action and any Stabilising
action, if begun, may be ended at any time. Any Stabilising action
or over-allotment shall be conducted in accordance with all
applicable laws and rules.
This announcement is for information purposes only and does not
constitute an invitation or offer to underwrite, subscribe for or
otherwise acquire or dispose of any securities of the Issuer in any
jurisdiction.
This announcement and the offer of the securities to which it
relates are only addressed to and directed at persons outside the
United Kingdom and persons in the United Kingdom who have
professional experience in matters related to investments or who
are high net worth persons within article 12(5) of the Financial
Services and Markets Act 2000 (Financial Promotion) Order 2005 and
must not be acted on or relied on by other persons in the United
Kingdom.
In addition, if and to the extent that this announcement is
communicated in, or the offer of the securities to which it relates
is made in, any EEA Member State that has implemented Directive
2003/71/EC (together with any applicable implementing measures in
any Member State, the "Prospectus Directive") before the
publication of a prospectus in relation to the securities which has
been approved by the competent authority in that Member State in
accordance with the Prospectus Directive (or which has been
approved by a competent authority in another Member State and
notified to the competent authority in that Member State in
accordance with the Prospectus Directive), this announcement and
the offer are only addressed to and directed at persons in that
Member State who are qualified investors within the meaning of the
Prospectus Directive (or who are other persons to whom the offer
may lawfully be addressed) and must not be acted on or relied on by
other persons in that Member State.
This announcement is not an offer of securities for sale into
the United States. The securities have not been, and will not be,
registered under the United States Securities Act of 1933 and may
not be offered or sold in the United States absent registration or
an exemption from registration. There will be no public offer of
securities in the United States.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
STAUPUCCCUPUGCQ
(END) Dow Jones Newswires
April 06, 2020 10:46 ET (14:46 GMT)
Sanofi (LSE:0A2V)
Historical Stock Chart
From Nov 2024 to Dec 2024
Sanofi (LSE:0A2V)
Historical Stock Chart
From Dec 2023 to Dec 2024